January 8 | 4 p.m. ET
RACE-Approved CE Credit Hours: 1
Free to attend
An upcoming webinar will highlight recent developments in the management of both squamous and glandular gastric disease, reviewing recent publications in the context of existing knowledge. Attendees will gain an understanding of the limitations of oral proton pump inhibitors and explore advances in newer generation PPIs, including extended-release injectable omeprazole. The session will also cover the published evidence supporting a range of treatment options for gastric disease.